Literature DB >> 33430785

Evaluation of a multi-component, non-pharmacological intervention to prevent and reduce sleep disturbances in people with dementia living in nursing homes (MoNoPol-sleep): study protocol for a cluster-randomized exploratory trial.

Martin N Dichter1,2,3, Almuth Berg4, Jonas Hylla5,6, Daniela Eggers7, Denise Wilfling7, Ralph Möhler8,9, Burkhard Haastert10, Gabriele Meyer4, Margareta Halek5,6, Sascha Köpke11,7.   

Abstract

BACKGROUND: Sleep problems are highly prevalent in people with dementia. Nevertheless, there is no "gold standard" intervention to prevent or reduce sleep problems in people with dementia. Existing interventions are characterized by a pronounced heterogeneity as well as insufficient knowledge about the possibilities and challenges of implementation. The aim of this study is to pilot and evaluate the effectiveness of a newly developed complex intervention to prevent and reduce sleep problems in people with dementia living in nursing homes.
METHODS: This study is a parallel group cluster-randomized controlled trial. The intervention consists of six components: (1) the assessment of established sleep-promoting interventions and an appropriate environment in the participating nursing homes, (2) the implementation of two "sleep nurses" as change agents per nursing home, (3) a basic education course for nursing staff: "Sleep problems in dementia", (4) an advanced education course for nursing staff: "Tailored problem-solving" (two workshops), (5) workshops: "Development of an institutional sleep-promoting concept" (two workshops with nursing management and sleep nurses) and (6) written information and education material (e.g. brochure and "One Minute Wonder" poster). The intervention will be performed over a period of 16 weeks and compared with usual care in the control group. Overall, 24 nursing homes in North, East and West Germany will be included and randomized in a 1:1 ratio. The primary outcome is the prevalence of sleep problems in people with dementia living in nursing homes. Secondary outcomes are quality of life, quality of sleep, daytime sleepiness and agitated behavior of people with dementia, as well as safety parameters like psychotropic medication, falls and physical restraints. The outcomes will be assessed using a mix of instruments based on self- and proxy-rating. A cost analysis and a process evaluation will be performed in conjunction with the study.
CONCLUSIONS: It is expected that the intervention will reduce the prevalence of sleep problems in people with dementia, thus not only improving the quality of life for people with dementia, but also relieving the burden on nursing staff caused by sleep problems. TRIAL REGISTRATION: Current controlled trials: ISRCTN36015309 . Date of registration: 06/11/2020.

Entities:  

Keywords:  Cluster-randomized controlled trial; Complex intervention; Dementia; Nursing; Nursing home; Sleep disturbances

Mesh:

Year:  2021        PMID: 33430785      PMCID: PMC7802225          DOI: 10.1186/s12877-020-01997-8

Source DB:  PubMed          Journal:  BMC Geriatr        ISSN: 1471-2318            Impact factor:   3.921


  55 in total

1.  The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Clifford M Singer; Jeffrey L Cummings; Leon J Thal
Journal:  J Sleep Res       Date:  2003-12       Impact factor: 3.981

Review 2.  Risk factors for sleep disturbances in older adults: Evidence from prospective studies.

Authors:  Stephen F Smagula; Katie L Stone; Anthony Fabio; Jane A Cauley
Journal:  Sleep Med Rev       Date:  2015-01-15       Impact factor: 11.609

3.  Implementation of a multicomponent intervention to prevent physical restraints in nursing homes (IMPRINT): A pragmatic cluster randomized controlled trial.

Authors:  Jens Abraham; Ramona Kupfer; Anja Behncke; Birte Berger-Höger; Andrea Icks; Burkhard Haastert; Gabriele Meyer; Sascha Köpke; Ralph Möhler
Journal:  Int J Nurs Stud       Date:  2019-04-04       Impact factor: 5.837

4.  Distress experienced by nurses in response to the challenging behaviour of residents - evidence from German nursing homes.

Authors:  Sascha G Schmidt; Martin N Dichter; Rebecca Palm; Hans Martin Hasselhorn
Journal:  J Clin Nurs       Date:  2012-11       Impact factor: 3.036

5.  Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.

Authors:  Laura Saarelainen; Anna-Maija Tolppanen; Marjaana Koponen; Antti Tanskanen; Reijo Sund; Jari Tiihonen; Sirpa Hartikainen; Heidi Taipale
Journal:  J Am Med Dir Assoc       Date:  2016-11-12       Impact factor: 4.669

6.  Implementing Dementia Care Mapping to develop person-centred care: results of a process evaluation within the Leben-QD II trial.

Authors:  Tina Quasdorf; Christine Riesner; Martin Nikolaus Dichter; Olga Dortmann; Sabine Bartholomeyczik; Margareta Halek
Journal:  J Clin Nurs       Date:  2016-12-07       Impact factor: 3.036

7.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

8.  A European study investigating patterns of transition from home care towards institutional dementia care: the protocol of a RightTimePlaceCare study.

Authors:  Hilde Verbeek; Gabriele Meyer; Helena Leino-Kilpi; Adelaida Zabalegui; Ingalill Rahm Hallberg; Kai Saks; Maria Eugenia Soto; David Challis; Dirk Sauerland; Jan P H Hamers
Journal:  BMC Public Health       Date:  2012-01-23       Impact factor: 3.295

9.  Nurses' burden caused by sleep disturbances of nursing home residents with dementia: multicenter cross-sectional study.

Authors:  Denise Wilfling; Martin N Dichter; Diana Trutschel; Sascha Köpke
Journal:  BMC Nurs       Date:  2020-09-09

10.  Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting.

Authors:  Aileen Grant; Shaun Treweek; Tobias Dreischulte; Robbie Foy; Bruce Guthrie
Journal:  Trials       Date:  2013-01-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.